AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Patient With Dyslipidemia

Efficacy and Safety of Pitavastatin/Ezetimibe in Dyslipidemia Patients With Metabolic Syndrome: An Observational Study NCT07523971n/a1 site๐Ÿ“ Daejeon JW Pharmaceutical Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Coronary Plaque Volumes Measured by Coronary Computed Tomography Angiography (CCTA) in Patients With Homozygous Familial Hypercholesterolemia (HoFH) NCT07447648n/a13 sites๐Ÿ“ Paris๐Ÿ“ Caserta๐Ÿ“ Catania Fondazione SISA (Societa Italiana per lo Studio della Arterโ€ฆ Bacillus Subtilis and Enterococcus Faecium Probiotic Plus Lipid-Lowering Therapy for Hypertriglyceridemic Acute Pancreatitis: A Prospective RCT NCT07720232Phase 41 site๐Ÿ“ Xiamen Jianyin Zhou ยท Tests: Live Combined Bacillus subtilis and Enterococcus faecium Enteric-coated Capsules (LCBE), Standard Care (in control arm) Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis NCT07307989Phase 21 site๐Ÿ“ Pozi Chang Gung Memorial Hospital ยท Tests: statin + ezetimibe, Statin monotherapy (rosuvastatin or atorvastatin) A Study of Bempedoic Acid or Its Single-pill Combination Therapy With Ezetimibe in Patients With Primary Hypercholesterolaemia or Mixed Dyslipidaemia NCT07206472n/a38 sites๐Ÿ“ Belo Horizonte๐Ÿ“ Belo Horizonte๐Ÿ“ Belo Horizonte Daiichi Sankyo ยท Tests: Combination of bempedoic acid and ezetimibe Assessment of Compliance With European and French Guidelines for the Management of Dyslipidaemias NCT03449784n/a1 site๐Ÿ“ Montpellier University Hospital, Montpellier ยท Tests: Detection of patients with dyslipidemia Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol NCT07028749Phase 255 sites๐Ÿ“ Anniston๐Ÿ“ Mobile๐Ÿ“ Little Rock Marea Therapeutics ยท Tests: MAR001, Placebo Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized Trial NCT05705804NA1 site๐Ÿ“ Seoul Yonsei University ยท Tests: Pitavastatin, Pitavastatin plus Ezetemibe, Atorvastatin The Effects of Xuezhikang and Atorvastatin on Lipid in Patients With Dyslipidemia and Prediabetes NCT06750783Phase 43 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Beijing Beijing Tsinghua Chang Gung Hospital ยท Tests: Xuezhikang, Atorvastatin Effects of Nattokinase on Inflammation and Cardiovascular Risk Markers in Patients With Dyslipidemia NCT06183307NA1 site๐Ÿ“ Rio de Janeiro Universidade Federal Fluminense ยท Tests: Nattokinase, Placebo A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia NCT06568471Phase 318 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Beijing Hasten Biopharmaceutical Co., Ltd. ยท Tests: Lerodalcibep, matching placebo Safety Evaluation of Gene Therapy Drug in the Treatment of Primary Hypertriglyceridemic Patients With Recurrent Pancreatitis NCT05860569Phase 11 site๐Ÿ“ Beijing GeneCradle Inc ยท Tests: GC304 A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia NCT07230730Phase 31 site๐Ÿ“ Hangzhou Beijing Suncadia Pharmaceuticals Co., Ltd ยท Tests: SHR-1918, SHR-1918 placebo Effect of Two Food Supplements on Lipid Profile in Patients With Mild Hypercholesterolemia NCT07295327NA1 site๐Ÿ“ Pavia Fondazione IRCCS Policlinico San Matteo di Pavia ยท Tests: Cynacol, Metacol Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy NCT06300450NA1 site๐Ÿ“ Boston Brigham and Women's Hospital ยท Tests: Computer Alert A Study to Evaluate the Efficacy and Safety of AD-218 NCT05400317Phase 31 site๐Ÿ“ Daegu Addpharma Inc. ยท Tests: AD-218, AD-218A A Study of SRSD216 in Patients With Elevated Lipoprotein (a) NCT07172646Phase 1, Phase 21 site๐Ÿ“ Beijing Sirius Therapeutics Co., Ltd. ยท Tests: SRSD216 injection, Placebo Study to Evaluate the Impact of a Targeted Lipid Optimization Program on LDL-C Control in At-risk Adult Patients With Dyslipidemia NCT07034690Phase 41 site๐Ÿ“ Abu Dhabi Novartis Pharmaceuticals ยท Tests: Educational Material, Standard of care A Extension Study to Evaluate the Safety and Efficacy of HRS-7249 in Patients With Hypertriglyceridemia NCT07799688Phase 22 sites๐Ÿ“ Jinan๐Ÿ“ Shanghai Fujian Shengdi Pharmaceutical Co., Ltd. ยท Tests: HRS-7249 Injection, HRS-7249 Injection Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia NCT05365425Phase 41 site๐Ÿ“ Seongnam-si Seoul National University Bundang Hospital ยท Tests: Choline fenofibrate, Policosanol Retinal Vascular Manifestations in Patients With Common Internal Diseases on OCTA Tomography Angiography NCT05644548n/a1 site๐Ÿ“ Beijing Beijing Tongren Hospital ยท Tests: No intervention Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or Dyslipidemia NCT06647888n/a1 site๐Ÿ“ Seoul Daewoong Pharmaceutical Co. LTD. ยท Tests: Envlo Tablet, Envlomet SR Tablet To Assess With Ezefeno Tab. in Patients With Dyslipidemia and T2DM NCT06293417NA1 site๐Ÿ“ Seoul Korea University Anam Hospital ยท Tests: Ezetimibe/fenofibrate (Ezefeno) and moderate-intensity statin, Dose escalation of moderate-intensity statin Group Medical Visits for Patients With Dyslipidemia NCT07543718NA1 site๐Ÿ“ Dieppe Universitรฉ de Sherbrooke ยท Tests: Group medical visits LATAM LOWERS LDL-C NCT06501443Phase 411 sites๐Ÿ“ Corrientes๐Ÿ“ Salvador๐Ÿ“ Belo Horizonte Novartis Pharmaceuticals ยท Tests: Usual care, KJX839 Pemafibrate for Symptomatic ICAS RCT NCT07562178NA37 sites๐Ÿ“ Toyoake๐Ÿ“ Yachiyo๐Ÿ“ Fukuyama Tokyo Women's Medical University ยท Tests: Pemafibrate Taiwan Green Propolis for Blood Lipids and Body Fat in Patients With MASLD NCT07692438NA1 site๐Ÿ“ Dalin Taipei Medical University ยท Tests: Taiwan green propolis capsule, Placebo capsule Phase 2 Clinical Study of MWX203 Injection Alone or in Combination With Inclisiran Sodium Injection in Patients With Mixed Dyslipidemia NCT07803822Phase 21 site๐Ÿ“ Beijing Shanghai Minwei Biotechnology Co., Ltd ยท Tests: MWX203, Inclisiran Sodium Injection, Placebo Impact of Obicetrapib and Obicetrapib Plus Repatha on Lp(a) Levels NCT06496243Phase 21 site๐Ÿ“ Philadelphia NewAmsterdam Pharma ยท Tests: obicetrapib 10 mg + obicetrapib/evolocumab 140 mg Q 2 weeks A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naรฏve Patients. NCT07619131Phase 3152 sites๐Ÿ“ Dothan๐Ÿ“ Chandler๐Ÿ“ Phoenix AstraZeneca ยท Tests: Laroprovstat, Rosuvastatin 1, Rosuvastatin 2, Laroprovstat/Rosuvastatin 1, Placebo to match rosuvastatin
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy